Clinical Trial Update: Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment [NA]

View source ↗

Summary

This ongoing study investigates a neoantigen-based peptide vaccine combined with conventional third-line therapy for colorectal cancer that progressed after sec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: The First Affiliated Hospital of Nanchang University | Conditions: Colorectal Cancer (CRC) | NA | Status: RECRUITING